As discussed previously, the serine 153 phosphorylated RKIP loses its ability to interact with RAF1 and regulate the ERK pathway, allowing cancer cells to utilize the cells’ own mechanisms of proliferation and migration, and similarly, a lack of RKIP also allows the ERK signaling pathway to remain active and deregulated. This evidence concerns the gene MAPK1 and cancer.